any take aways yet? I registered and can see the slides, but the audio is very faint so I cannot hear it properly. my speaker volume are set as loud as possible, so I am not sure of the technical problem with the presentation's audio.
He reported basically all info available on CLDX studies.
Investigators are very interested in future studies of CDX-011.
Main side effect - peripheral neuropathy was not a factor in the treatments. Patients with a history of peripheral neuropathy had exacerbation of the neuropathy but in patients with no history of neuropathy...there were no issues.